Zeyana S. Rivera, Ph.D. - Publications

Affiliations: 
2011 University of Hawai'i at Manoa, Honolulu, HI 
Area:
Molecular Biology, Immunology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Jube SL, Rivera Z, Casalgrandi M, Bianchi M, Pass HI, Gaudino G, Carbone M, Yang H. Abstract 5557: BoxA and ethyl pyruvate offer novel therapeutic approaches for human malignant mesothelioma. Cancer Research. 73: 5557-5557. DOI: 10.1158/1538-7445.Am2013-5557  0.595
2013 Croce A, Musa M, Allegrina M, Rinaudo C, Baris YI, Dogan AU, Powers A, Rivera Z, Bertino P, Yang H, Gaudino G, Carbone M. Micro-Raman spectroscopy identifies crocidolite and erionite fibers in tissue sections Journal of Raman Spectroscopy. 44: 1440-1445. DOI: 10.1002/Jrs.4286  0.475
2012 Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63. PMID 22893632 DOI: 10.1158/1078-0432.Ccr-12-0628  0.54
2012 Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Research. 72: 3290-301. PMID 22552293 DOI: 10.1158/0008-5472.Can-11-3481  0.577
2012 Jube S, Rivera Z, Bianchi M, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Abstract 1557: High mobility group box 1 secretion supports tumor progression of human malignant mesothelioma Cancer Research. 72: 1557-1557. DOI: 10.1158/1538-7445.Am2012-1557  0.585
2011 Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43: 1022-5. PMID 21874000 DOI: 10.1038/Ng.912  0.563
2011 Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. 108: 13618-23. PMID 21788493 DOI: 10.1073/Pnas.1105887108  0.594
2011 Jube S, Rivera Z, Gaudino G, Pass HI, Bianchi ME, Carbone M, Yang H. Abstract 2600: HMGB1, a potential new target for mesothelioma therapy Cancer Research. 71: 2600-2600. DOI: 10.1158/1538-7445.Am2011-2600  0.586
2010 Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6. PMID 20616036 DOI: 10.1073/Pnas.1006542107  0.601
2009 Yang H, Nasu M, Strianese O, Rivera Z, Luecke L, Carbone M. The legacy of "miracle mineral": asbestos and cancer. Hawaii Medical Journal. 68: 18-20. PMID 19365925  0.552
2008 Rivera Z, Strianese O, Bertino P, Yang H, Pass H, Carbone M. The relationship between simian virus 40 and mesothelioma. Current Opinion in Pulmonary Medicine. 14: 316-21. PMID 18520265 DOI: 10.1097/Mcp.0B013E3283018220  0.49
Show low-probability matches.